ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Patient reported outcomes"

  • Abstract Number: 1238 • ACR Convergence 2024

    Role of Patient Reported Outcomes in Predicting Disease Relapse at One Year in Those with Polymyalgia Rheumatica

    Patricia Harkins1, Sharon Cowley2, seoidin McKittrick3, Robert Harrington4, David Kane5 and Richard Conway6, 1Trinity College Dublin, Dublin 8, Dublin, Ireland, 2Tallaght University Hospital, Dublin, Dublin, Dublin, Ireland, 3University of Limerick, Limerick, Ireland, 4St. James's Hospital, Dublin, Dublin, Ireland, 5Tallaght University Hospital & Trinity College Dublin, D24, Ireland, 6Trinity College Dublin, Dublin, Ireland

    Background/Purpose: One of the most significant unmet needs in the management of those with Polymyalgia Rheumatica (PMR)  is the lack of a disease stratification tool…
  • Abstract Number: 1331 • ACR Convergence 2024

    Does Refractory Rheumatoid Arthritis Status Matter in Modeling Patient Global Assessment Trajectories over 20 Years in a Large US Registry?

    Sofia Pedro1, Kristin Wipfler2, Urbano Sbarigia3, Federico Zazzetti4, Anna Sheahan5, Patti Katz6 and Kaleb Michaud7, 1Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 2FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 3Johnson & Johnson Innovative Medicine, Brussels, Belgium, 4Johnson & Johnson Innovative Medicine, Horsham, PA, PA, 5Janssen, Chapel Hill, NC, 6UCSF, San Rafael, CA, 7University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Refractory rheumatoid arthritis (reRA) is characterized by an inadequate response to multiple DMARDs. Many factors including environment, comorbidities, sociodemographics, and the treatment itself influence poor…
  • Abstract Number: 1563 • ACR Convergence 2024

    Prevalence, Risk Factors and Associations for Osteoporosis in Postmenopausal Women with Scleroderma

    Gayane Matusov1, Jon Giles2 and Francesco Boin3, 1Scripps Clinic, San Diego, CA, 2Cedars Sinai Medical Center, Los Angeles, CA, 3Cedars-Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Case-control studies have shown that systemic sclerosis (SSc) patients exhibit higher prevalence of osteoporosis (OP) compared to subjects in the general population. The pathophysiology…
  • Abstract Number: 2154 • ACR Convergence 2024

    “I Have Taken Five Different Kinds of Tablets and Injections, and I Still Have Foot Pain”: An International Outcome Measures in Rheumatology (OMERACT) Qualitative Study Exploring Patient Perspectives of Foot and Ankle Disorders

    Lara Chapman1, Caroline Flurey2, Anthony C. Redmond1, Pam Richards3, Eiman Soliman4, Abdelhfeez Moshrif5, Lucy Malone6, Christopher Joyce7, Marian Hannan8, Philip S. Helliwell9, Catherine Hofstetter10, Hylton Menz11, Beverley Shea12 and Heidi Siddle1, 1University of Leeds, Leeds, United Kingdom, 2University of the West of England, Bristol, Bristol, United Kingdom, 3OMERACT, Bristol, United Kingdom, 4Alexandria Faculty of Medicine, Alexandria, Egypt, 5Al-azhar university, Assiut, Egypt, 6Harrogate and District NHS Foundation Trust, Harrogate, United Kingdom, 7Homerton Healthcare NHS Foundation Trust, London, United Kingdom, 8Marcus Institute for Aging Research, Hebrew SeniorLife, Milton, MA, 9Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, Leeds, United Kingdom, 10OMERACT, Toronto, Canada, 11La Trobe University, Fairfield, Victoria, Australia, 12Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Background/Purpose: The foot and ankle are frequently affected in rheumatic and musculoskeletal diseases (RMDs), yet there is a lack of high-quality evidence to determine the…
  • Abstract Number: 2336 • ACR Convergence 2024

    Patients with Psoriasis with a Positive Psoriasis Epidemiology Screening Tool (PEST): Similarities and Differences Compared to PsA and Patients with Psoriasis and a Negative PEST

    Alexis Ogdie1, William Song2, Joel Gelfand2, Sarah Lonowski3, Rebecca Schumacher4 and Kaleb Michaud3, 1Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3University of Nebraska Medical Center, Omaha, NE, 4Forward Databank, Witchita, KS

    Background/Purpose: Identifying patients at risk for developing psoriatic arthritis (PsA) may allow for accelerated diagnosis and treatment and improve long term outcomes for these patients.…
  • Abstract Number: 0223 • ACR Convergence 2024

    A Comparative Study of Difficult-to-Treat vs Non-Difficult-to-Treat Psoriatic Arthritis for Disease Burden and Comorbidities: An Ultrasound Study

    Ricardo Sabido-Sauri1, Seyyid Bilal Acikgoz2, Ozun Bayindir Tsechelidis3, Ummugulsum Gazel1, Sylvia Sangwa4, Elliot Hepworth1 and Sibel Aydin5, 1University of Ottawa, Ottawa, ON, Canada, 2University of Ottawa, Rheumatology, Ottawa, ON, Canada, 3Ottawa University, Ottawa, ON, Canada, 4The Ottawa Hospital Research Institute, Ottawa, Canada, 5University of Ottawa - Ottawa, Ottawa, ON, Canada

    Background/Purpose: In the era of several advanced therapies and an increased number of patients with psoriatic arthritis (PsA) who have been failed by multiple treatment…
  • Abstract Number: 0561 • ACR Convergence 2024

    Axial Spondyloarthritis Patients with Comorbid Fibromyalgia Feel Worse, Work Less and More Often Try Multiple Biological DMARDs − Results from a Population-Based Cohort

    Annie Brink1, Elisabeth Mogard2, Elisabet Lindqvist2, Jonas Sagard2, Johan Karlsson Wallman1 and Tor Olofsson2, 1Lund University, Department of Clinical Sciences Lund, Section of Rheumatology and Skåne University Hospital, Lund, Sweden, Lund, Skane Lan, Sweden, 2Lund University, Department of Clinical Sciences Lund, Section of Rheumatology and Skåne University Hospital, Lund, Sweden, Lund, Sweden

    Background/Purpose: A growing arsenal of biologic/targeted synthetic DMARDs often makes inflammation control an attainable target in axial spondyloarthritis (axSpA). Yet, many patients keep suffering from…
  • Abstract Number: 0720 • ACR Convergence 2024

    Impact of Systemic Vasculitides on Sexual Function: An Overlooked Aspect of Patient Care

    javier Merayo Chalico1, Ana Sarahí Mulia-Soto2, María Espinosa-León3, Victor Pimentel-Quiroz4, Ana Barrera-Vargas3 and Andrea Hinojosa-Azaola3, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, CDMX, Mexico, 2Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Ciudad de México, Mexico, 3Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico City, Mexico, 4Universidad Científica del Sur/Hospital Nacional Guillermo Almenara Irigoyen, Magdalena del Mar, Peru

    Background/Purpose: Systemic vasculitides comprise a group of inflammatory diseases involving multiple organ systems, significantly affecting various aspects of a patient's life, including their sexuality. Sexual…
  • Abstract Number: 1242 • ACR Convergence 2024

    Qualitative Patient Interview Study in Patients with Systemic Lupus Erythematosus to Assess Patient Perception of Fatigue and Skin-Related Symptoms

    Joseph F. Merola1, Victoria Werth2, Jiyoon C. Choi3, Brandon Becker3, Teresa Edwards4, Coburn Hobar5, Samantha Pomponi5 and Vibeke Strand6, 1UT Southwestern Medical Center, Dallas, TX, 2Hospital of the University of Pennsylvania, Philadelphia, PA, 3Bristol Myers Squibb, Princeton, 4RTI International, Research Triangle Park, NC, 5Bristol Myers Squibb, Princeton, NJ, 6Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that disproportionately impacts women of childbearing age. Although the incidence varies widely based on ethnic…
  • Abstract Number: 1332 • ACR Convergence 2024

    Financial Distress and Its Determinants in Adults with Rheumatoid Arthritis

    Amber Brown Keebler1, Yunju Im2, Sofia Pedro3, Ted Mikuls1, Edward Peters1 and Kaleb Michaud1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Omaha, 3Forward, The National Databank for Rheumatic Diseases, Wichita, KS

    Background/Purpose: Often not evaluated in clinical visits, financial distress associated with medical costs, also known as financial toxicity, has emerged as an important factor affecting…
  • Abstract Number: 1576 • ACR Convergence 2024

    New Patient-Reported Outcome Measures for Early Systemic Sclerosis Using the FDA Guidance on Patient Reported Outcome Measures

    Dinesh Khanna1, George greene2, Chelsea Perschon2, Alain Lescoat3, Emilie Jaeger2, Susan murphy1 and David Cella4, 1University of Michigan, Ann Arbor, MI, 2Northwestern University, Chicago, 3CHU Rennes - University Rennes 1, Rennes, France, 4Northwestern University, Chicago, IL

    Background/Purpose: Systemic sclerosis (SSc) is associated with a wide range of symptoms and significant impairments in function and quality of life. The goal of the…
  • Abstract Number: 2155 • ACR Convergence 2024

    Direct Comparison of Sleep Quality and Risk Factors for Poor Sleep Across Rheumatoid Arthritis, Axial Spondyloarthritis and Psoriatic Arthritis

    Dagna Polak1, Mateusz Wilk2, Piotr Kuszmiersz1, Glenn Haugeberg3, Mariusz Korkosz4 and Zofia Guła4, 1University Hospital in Cracow, Kraków, Poland, 2Univesity Hospital in Cracow, Kraków, Poland, 3Sørlandet Hospital, Kristiansand, Kristiansand, Norway, 4Department of Rheumatology and Immunology, Jagiellonian University Medical College, Kraków, Poland

    Background/Purpose: Sleep disorders are common among patients with inflammatory arthritis (IA) and have probably bilateral influence on disease activity and quality of life. Pathomechanism of…
  • Abstract Number: 2365 • ACR Convergence 2024

    Benefits of Achieving Early versus Late Clinical Response After Treatment with Biologic and Targeted Synthetic DMARDs Among Patients with PsA in the CorEvitas PsA/Spondyloarthritis Registry

    Philip Mease1, Xiaolan Ye2, Christopher Saffore3, Thomas Iyile4, Priscila Magalhaes Reis Nakasato5, Taylor Blachley6, Paul R. Lakin6, Nicole Middaugh6 and Alexis Ogdie7, 1Swedish Medical Center/Providence St. Joseph Health; University of Washington School of Medicine, Seattle, WA, 2AbbVie Inc., Mettawa, IL, 3AbbVie Inc., waukegan, IL, 4AbbVie Inc., hyattsville, MD, 5AbbVie Inc., Randolph, NJ, 6CorEvitas, LLC, Waltham, MA, 7Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Treatment for psoriatic arthritis (PsA) often involves biologic and targeted synthetic DMARDs (b/tsDMARDs). Existing research suggests that starting treatment with b/tsDMARDs early may lead…
  • Abstract Number: 0264 • ACR Convergence 2024

    Clinical Value of Metagenomic Next-generation Sequencing in Patients with Connective Tissue Disease Co-infections: A Single-center Study from Southern Hospital in China

    Yuan-Yuan Xiao1, Ai-Ling Lu1, Han-You Mo2, Zhen-Dong He2, Jia-Le Wen2 and Xuan Yin1, 1Guilin Medical University, Guilin, China (People's Republic), 2The First Affiliated Hospital of Guangxi Medical University, Nanning, China (People's Republic)

    Background/Purpose: Few studies have been reported on the use of metagenomic next-generation sequencing (mNGS) in patients with connective tissue disease (CTD) co-infections, and more relatively large-scale data…
  • Abstract Number: 0571 • ACR Convergence 2024

    Gender-specific Performance of Disease Activity Assessment Tools in Axial Spondyloarthritis: Ancillary Analysis of the PREDICT-SpA Study

    Sabrina Hamroun1, Laure Gossec2, Serge Perrot3, Maxime Dougados4 and Anna Molto5, 1Cochin University Hospital, Paris, Ile-de-France, France, 2Sorbonne Université, Paris, France, 3Paris Dauphine University, Paris, France, 4Rheumatology Department, Cochin Hospital and Clinical Epidemiology and Biostatistics, University of Paris, INSERM (U1153), Paris, France, 5Groupe Hospitalier Cochin, AP-HP, Paris, France

    Background/Purpose: There are several tools for assessing disease activity in spondyloarthritis (SpA). The literature reveals gender differences, with unfavorable Patient Reported Outcomes in women compared…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 43
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology